Liquid and solid dosage form strategy focused on stability, inovation, and lifecycle performance.
Identification and mitigation of drug discovery and development risks across all stages.
Risk-based E&L strategy including material selection, assessment, and regulatory justification.
Statistical monitoring and CPV frameworks for late-stage and commercial manufacturing.
Efficient experimental design to understand processes and define robust operating ranges.
Planning and execution of tech transfer, scale-up, and manufacturing site readiness.
Packaging selection and analysis with focus on stability, compatibility, and regulatory impact.
Writing, coordination, and execution of EU-funded scientific and innovation projects.
Applied statistics and modeling to support formulation, process, and development decisions.